Outlook Therapeutics Inc.

NASDAQ: OTLK · Real-Time Price · USD
2.35
-0.08 (-3.29%)
At close: Aug 15, 2025, 3:59 PM
2.39
1.92%
After-hours: Aug 15, 2025, 06:08 PM EDT

Outlook Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Net Income
-75.37M -58.98M -66.05M -53.16M
Depreciation & Amortization
113.86K 44.19K 204.69K 262.14K
Stock-Based Compensation
5.39M 5.55M 7.71M 4.89M
Other Working Capital
-4.41M 1.67M -2.98M -6.88M
Other Non-Cash Items
4.09M 5.66M 3.15M 341.55K
Deferred Income Tax
n/a n/a n/a 498.49K
Change in Working Capital
-3.02M 4.75M -1.68M -7.08M
Operating Cash Flow
-68.79M -42.97M -56.67M -54.25M
Capital Expenditures
n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
-4.27K 19.77M -2.32M 6.31M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -823.89K -394.15K 3.59M
Financial Cash Flow
60.33M 48.97M 59.59M 56.19M
Net Cash Flow
-8.46M 6M 2.92M 1.94M
Free Cash Flow
-68.79M -42.97M -56.67M -54.25M